chr8-17864722-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_004467.4(FGL1):āc.809A>Gā(p.Tyr270Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000553 in 1,590,414 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004467.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGL1 | NM_004467.4 | c.809A>G | p.Tyr270Cys | missense_variant | 8/8 | ENST00000427924.5 | NP_004458.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGL1 | ENST00000427924.5 | c.809A>G | p.Tyr270Cys | missense_variant | 8/8 | 1 | NM_004467.4 | ENSP00000401952.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151918Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000260 AC: 6AN: 231130Hom.: 0 AF XY: 0.0000239 AC XY: 3AN XY: 125576
GnomAD4 exome AF: 0.0000591 AC: 85AN: 1438496Hom.: 0 Cov.: 31 AF XY: 0.0000489 AC XY: 35AN XY: 715354
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151918Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74184
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2024 | The c.809A>G (p.Y270C) alteration is located in exon 9 (coding exon 7) of the FGL1 gene. This alteration results from a A to G substitution at nucleotide position 809, causing the tyrosine (Y) at amino acid position 270 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at